M 1145 acetate

TargetMol
Product Code: TAR-TP1991L
Supplier: TargetMol
CodeSizePrice
TAR-TP1991L-1mg1mg£568.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-2mg2mg£812.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-5mg5mg£1,187.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-10mg10mg£1,669.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-25mg25mg£2,448.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-50mg50mg£3,275.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1991L-100mg100mg£4,400.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Further Information

Bioactivity:
M1145 acetate, a chimeric peptide, is a selective galanin receptor type 2 (GAL2) agonist, with a Ki of 6.55 nM. M1145 acetate shows more than 90-fold higher affinity for GAL2 over GAL1 (Ki=587 nM) and a 76-fold higher affinity over GalR3 (Ki=497 nM). M1145 acetate has an additive effect on the signal transduction of galanin[1].
CAS:
0
Formula:
C130H209N37O34
Molecular Weight:
2834.28
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.991
SMILES:
CC(O)=O.C[C@@H](C(N)=O)NC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](C)NC([C@H]1N(C([C@H]2N(C([C@H]3N(C([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@H]4N(C(CNC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC5=CC=C(O)C=C5)NC(CNC([C@H](C)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@H](CC(C)C)NC([C@H]([C@H](O)C)NC([C@H](CC6=CNC7=C6C=CC=C7)NC([C@H](CC(N)=O)NC(CNC([C@H](CCCNC(N)=N)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC4)=O)=O)=O)CCC3)=O)CCC2)=O)CCC1)=O)=O)=O)=O)=O
Target:
Neuropeptide Y Receptor

References

Runesson J, Saar I, Lundstr?m L, J?rv J, Langel U. A novel GalR2-specific peptide agonist. Neuropeptides. 2009;43(3):187-192.